MFS
ADMA icon

Mirabella Financial Services’s ADMA Biologics ADMA Stock Holding History

Mirabella Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,644
Closed -$159K – 683
2026
Q1 		$159K Buy
+17,644
New +$278K 0.02% 809
2022
Q2 		– Sell
-101,510
Closed -$186K – 450
2022
Q1 		$186K Buy
+101,510
New +$158K 0.02% 408

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mirabella Financial Services's ADMA Position: Q2 2026 in Review

Mirabella Financial Services sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 17,644 shares — an estimated $159K sold.

Mirabella Financial Services first reported a position in ADMA in Q1 2022 and held it in 2 quarters. The position peaked at $186K in Q1 2022. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Mirabella Financial Services reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 17,644 ADMA Biologics shares in Q2 2026, an estimated $159K.
  • Mirabella Financial Services first reported a position in ADMA Biologics in Q1 2022 and held it in 2 quarters.
  • Mirabella Financial Services's ADMA Biologics position peaked at $186K in Q1 2022.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.